Effect of High Dose Active Vitamin D Therapy on the Development of Hypocalcemia After Subtotal Parathyroidectomy in Patients on Chronic Dialysis.

Malina GrubeFrank WeberAnna Lena KahlAndreas KribbenNils MüllingWalter Reinhardt

Published in: International journal of nephrology and renovascular disease (2021)

The period after PTx in dialysis patients is characterized by an expected drop in PTH and calcium within the first days. Ongoing high turnover is observed in the 2nd and 3rd week after PTx. Administering high doses of alfacalcidol combined with calcium acetate diminishes the episodes of severe hypocalcemia and the need for intravenous calcium.

Keyphrases

end stage renal disease
chronic kidney disease
high dose
peritoneal dialysis
ejection fraction
newly diagnosed
clinical trial
stem cells
low dose
early onset
bone marrow
mesenchymal stem cells
patient reported
bone mineral density
cell therapy
replacement therapy